Zacks Research Upgrades Astrana Health (NASDAQ:ASTH) to “Hold”

Astrana Health (NASDAQ:ASTH) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

A number of other research firms have also weighed in on ASTH. BTIG Research cut their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Barclays cut their target price on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Monday, November 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. TD Cowen cut their target price on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $41.33.

Astrana Health Trading Down 3.3%

NASDAQ ASTH traded down $0.89 on Monday, reaching $26.23. 58,298 shares of the company were exchanged, compared to its average volume of 478,848. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. The business’s fifty day moving average price is $24.24 and its 200 day moving average price is $26.84. The stock has a market capitalization of $1.48 billion, a P/E ratio of 138.38, a price-to-earnings-growth ratio of 0.73 and a beta of 0.87. Astrana Health has a fifty-two week low of $20.12 and a fifty-two week high of $39.97.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The firm had revenue of $956.05 million for the quarter, compared to analysts’ expectations of $952.83 million. During the same period last year, the firm earned $0.33 earnings per share. Astrana Health’s revenue for the quarter was up 99.7% on a year-over-year basis. Analysts forecast that Astrana Health will post 1.15 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its holdings in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares during the last quarter. Covestor Ltd grew its holdings in Astrana Health by 210.6% in the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after buying an additional 2,192 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares during the period. State of Wyoming acquired a new position in Astrana Health during the 2nd quarter worth $132,000. Finally, Citizens Financial Group Inc. RI bought a new position in shares of Astrana Health in the third quarter worth $204,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.